Discontinued — last reported Q3 '25
F5, Inc. Equity Method Investments increased by 15.9% to $20.81M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 66.1%, from $12.53M to $20.81M. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows a downward trend with a -31.4% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $95.22M | $132.78M | $76.99M | $34.91M | $19.11M | $9.54M | $7.81M | $4.74M | $5.89M | $5.07M | $6.17M | $6.34M | $7.30M | $8.58M | $11.18M | $12.53M | $15.03M | $15.69M | $17.97M | $20.81M |
| QoQ Change | — | +39.4% | -42.0% | -54.7% | -45.3% | -50.1% | -18.1% | -39.4% | +24.3% | -13.9% | +21.7% | +2.8% | +15.1% | +17.6% | +30.3% | +12.1% | +19.9% | +4.4% | +14.5% | +15.9% |
| YoY Change | — | — | — | — | -79.9% | -92.8% | -89.9% | -86.4% | -69.2% | -46.9% | -21.0% | +33.9% | +24.0% | +69.3% | +81.2% | +97.6% | +106.0% | +82.9% | +60.7% | +66.1% |